Below trend growth to continue
Treasurer Frydenberg today stated JobKeeper numbers have more than halved from a peak of 3.6m, to now just 1.5m as at 26 November.
The RBA and Q3 GDP figures dominate the week. The RBA Board meets on Tuesday and Governor Lowe gives Parliamentary Testimony on Wednesday. While the RBA only recently eased policy, a run of better than expected data now has markets asking what happens in five months when the $100bn QE program expires – will it be a hard stop given the pick-up in the data and would this have any implications for the 3yr YCC program?
Datawise Q3 GDP figures are out Wednesday where NAB looks for an above consensus 4.1% q/q rise after last quarter’s sharp 7% contraction. There is a wide range on the consensus for GDP (range 0.5-4.1%; median 2.4%) which may narrow after Net Exports/Government Spending on Tuesday.
Also out in the week are on Tuesday, Trade Balance and Housing Finance on Thursday, and final Retail Sales on Friday.
Vaccine hopes dominate with talk of fast-track approval of the Pfizer/BioNTech vaccine in the UK by December 7, and in the US soon after that. Accordingly, markets may become less sensitive to any data misses in what is a big week for data.
US: Payrolls are on Friday with consensus +500k and for the unemployment rate to tick down a tenth to 6.8%.
The ISMs are also out on Tuesday and Thursday.
Fed Chair Powell is speaking before the Senate and House on Tuesday and Wednesday, having already steered markets toward a QE twist announcement at the upcoming December FOMC meeting.
UK/EU: the press report a UK-EU trade deal may be finalised this week, while the Euro area has a flash read on inflation on Tuesday.
Customers can receive Australian Markets Weekly and other updates directly in their inbox by emailing firstname.lastname@example.org with the name of their NAB relationship manager.
© National Australia Bank Limited. ABN 12 004 044 937 AFSL and Australian Credit Licence 230686.